Consensus Guideline for the Management of Patients with Peritoneal Mesothelioma
Preprint in medRxiv (April 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Formalin-Fixed Paraffin-Embedded Proteomics of Malignant Mesothelioma and New Candidate Biomarkers Thioredoxin and Superoxide Dismutase 2 for Immunohistochemistry
Article in Laboratory Investigation (November 2023)
Cost-effectiveness analysis of nivolumab versus placebo for relapsed malignant mesothelioma
Article in International Journal of Clinical Pharmacy (November 2023)